SharpMed
About this raise
SharpMed is raising funds on Republic. The company makes transformative medical devices and delivers advanced and cost-effective medical devices to hospitals. SharpMed’s flagship product, Turbo O2 Cap, has FDA Class 1 clearance and will work as a lifeline in critical moments by preventing dangerous drops in oxygen levels during intubation. The product of SharpMed is 95% ready and is ready for its commercial launch in 2024. Dr. Chris Salvino founded SharpMed in December 2015. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $1.2 million. The campaign proceeds will be used for new product marketing, research and development, new hires, and general working capital.
Investment Overview
Invested $212,160 :
Deal Terms
Company & Team
Company
- Year Founded
- 2015
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B
- Margin
- Medium
- Capital Intensity
- High
Team
- Employees
- 2
- Prior Founder Exits?
- No
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $0
- VC Backed?
- No
Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|
11/15/2024 | Republic | $22,090,000 | $212,160 | Equity - Common | Funded | RegCF |